Clinical trial
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
NCT02934477 is registered in ClinicalTrials.gov with Center for International Blood and Marrow Transplant Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- Lead sponsor
- Center for International Blood and Marrow Transplant Research
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 30, 2016
- Completion date
- October 31, 2027
- Enrollment
- 650 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myelofibrosis